Skip navigation

DSpace JSPUI

DSpace preserves and enables easy and open access to all types of digital content including text, images, moving images, mpegs and data sets

Learn More
DSpace logo
English
中文
  • Browse
    • Communities
      & Collections
    • Publication Year
    • Author
    • Title
    • Subject
  • Search TDR
  • Rights Q&A
    • My Page
    • Receive email
      updates
    • Edit Profile
  1. NTU Theses and Dissertations Repository
  2. 醫學院
  3. 國際三校農業生技與健康醫療碩士學位學程
Please use this identifier to cite or link to this item: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/89788
Title: 藥品可及性的跨大陸比較分析
A cross-continental comparative analysis of the drug access system
Authors: 張靖瀅
Ching-Ying Chang
Advisor: 李財坤
Tsai-Kun Li
Keyword: 藥品可及性延遲,藥品定價,藥品納入健保延遲,
Drug access delay,market authorization,pricing delays,reimbursement delays,
Publication Year : 2023
Degree: 碩士
Abstract: 藥品可及性延遲是藥證取得、藥品定價、藥品納入健保延遲所得到的結果,這 會對個人的健康和財政狀況造成負面影響。本文利用各國衛生主管機關公開的資 料,比較分析北美、歐洲、亞洲等不同大陸間的藥品可及性、新藥申請、藥品定 價等過程及系統,並透過 Cyramza (Ramucirumab) 和 Zejula (Niraparib)這兩個藥 品的案例分析,來強化論述。此分析總結出藥證取得延遲通常各國相似,但是藥 品納入健保卻因為各國投入健保的預算及當地未滿足醫療需求不同,而造成相當 大的延遲差異,總體來說,這個比較分析報告提供了不同大陸間製藥產業的法規 和定價系統有價值的洞見,以期待能增加藥品可及性。
Drug access delays, including market authorization, pricing, and reimbursement delays, can significantly impact individuals' health and wealth. The study analyzes drug access, new drug approval processes, and pricing systems in several continents, including North America, Europe, and Asia, based on data disclosed by their regulatory authorities. The analysis relies on two case studies (Cyramza (Ramucirumab) and Zejula (Niraparib)) to strengthen the finding. This report finds that the market authorization waiting time is usually similar within countries. However, reimbursement delays can vary significantly because of the healthcare budget and national unmet medical needs differences. Overall, the comparative analysis provides valuable insights into the pharmaceutical industry's regulatory frameworks and pricing mechanisms in different regions, emphasizing the need for ongoing policy development to improve drug access and affordability globally.
URI: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/89788
DOI: 10.6342/NTU202301699
Fulltext Rights: 同意授權(全球公開)
metadata.dc.date.embargo-lift: 2025-08-15
Appears in Collections:國際三校農業生技與健康醫療碩士學位學程

Files in This Item:
File SizeFormat 
ntu-111-2.pdf
  Until 2025-08-15
732.76 kBAdobe PDF
Show full item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved